Stockreport

Aileron Therapeutics Announces Plans to Release Interim Results from its Phase 1b/2 Myelopreservation Study in Mid-2020

Aileron Therapeutics, Inc.  (ALRN) 
Last aileron therapeutics, inc. earnings: 11/7 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.aileronrx.com
PDF Presentation of interim results from the dose-optimization part of the Phase 1b myelopreservation study - - - Final data readout from Phase 1b for both dose optimization [Read more]